Related Experiment Video
Updated: Mar 21, 2026
Differentiation of Embryonic Stem Cells into Oligodendrocyte Precursors
Published on: May 19, 2010
Sequential Differentiation of Embryonic Stem Cells into Neural Epithelial-Like Stem Cells and Oligodendrocyte
Jing Bian1, Jiao Zheng2, Shen Li1
1Jiangsu Key Laboratory of Neuroregeneration, Collaborative Innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu, China.
Background:
Recent advances in stem cell technology afford an unlimited source of neural progenitors and glial cells for cell based therapy in central nervous system (CNS) disorders. However, current differentiation strategies still need to be improved due to time-consuming processes, poorly defined culture conditions, and low yield of target cell populations.
Methodology/Principle Findings:
This study aimed to provide a precise sequential differentiation to capture two transient stages: neural epithelia-like stem cells (NESCs) and oligodendrocytes progenitor cells (OPCs) derived from mouse embryonic stem cells (ESCs). CHIR99021, a glycogen synthase kinase 3 (GSK-3) inhibitor, in combination with dual SMAD inhibitors, could induce ESCs to rapidly differentiate into neural rosette-like colonies, which facilitated robust generation of NESCs that had a high self-renewal capability and stable neuronal and glial differentiation potentials. Furthermore, SHH combined with FGF-2 and PDGF-AA could induce NESCs to differentiate into highly expandable OPCs. These OPCs not only robustly differentiated into oligodendrocytes, but also displayed an increased migratory activity in vitro.
Conclusions/Significance:
We developed a precise and reliable strategy for sequential differentiation to capture NESCs and OPCs derived from ESCs, thus providing unlimited cell source for cell transplantation and drug screening towards CNS repair.
Insights
Researchers developed a new method to efficiently generate neural stem cells and oligodendrocyte progenitor cells from mouse embryonic stem cells, offering a promising cell source for central nervous system repair and drug screening.
Area of Science:
- Stem cell biology
- Neuroscience
- Developmental biology
Background:
- Stem cell technology offers potential for central nervous system (CNS) disorder therapies.
- Current differentiation methods are inefficient, time-consuming, and yield low numbers of target cells.
Purpose of the Study:
- To establish a precise sequential differentiation strategy for generating neural epithelia-like stem cells (NESCs) and oligodendrocyte progenitor cells (OPCs) from mouse embryonic stem cells (ESCs).
Main Methods:
- ESCs were induced to differentiate into neural rosette-like colonies using a GSK-3 inhibitor (CHIR99021) and dual SMAD inhibitors.
- NESCs were then differentiated into OPCs using SHH, FGF-2, and PDGF-AA.
Main Results:
- The method rapidly generated NESCs with high self-renewal and differentiation potential.
- OPCs derived from NESCs showed robust differentiation into oligodendrocytes and enhanced in vitro migratory activity.
Conclusions:
- A reliable strategy for sequential differentiation of ESCs into NESCs and OPCs was developed.
- This approach provides an unlimited cell source for CNS repair, cell transplantation, and drug screening.
